Dianthus Therapeutics is a clinical-stage biotechnology company dedicated to transforming the treatment landscape for patients with severe autoimmune diseases. By leveraging advanced antibody engineering and proprietary bifunctional inhibitor technology, the company aims to replace frequent, burdensome treatments with more convenient, long-acting therapeutic options.
Driven by a culture of scientific excellence, Dianthus operates at the intersection of innovation and accessibility. The company empowers its team members by offering flexible, remote-friendly work environments, ensuring that world-class talent can contribute to life-changing science regardless of location.